*April 2021*
In this podcast, Drs. H. Jack West, Helena Yu, and David Spigel discuss the addition of SBRT to a systemic EGFR inhibitor TKI in EGFR positive NSCLC.
*April 2021*
In this podcast, Drs. H. Jack West, Helena Yu, and David Spigel discuss the addition of SBRT to a systemic EGFR inhibitor TKI in EGFR positive NSCLC.





The EGFR Resisters is a global community of patients and caregivers impacted by EGFR-positive lung cancer. We’re here to share knowledge, offer support and collaborate to drive progress in research and care. We are here to share treatment experiences, information about clinical trials, breaking news about research developments, and other information with each other.
